Divide and conquer: Nucleotide excision repair battles cancer and ageing

Current Opinion in Cell Biology

Volumn 15, Issue 2, 2003, Pages 232-240

  Mitchell, James R ^a   Hoeijmakers, Jan H J ^a   Niedernhofer, Laura J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATION; AGING; CANCER; CARCINOGENESIS; COCKAYNE SYNDROME; CYTOTOXICITY; DNA DAMAGE; DNA METABOLISM; DNA REPAIR; EXCISION REPAIR; GENOME; HUMAN; LONGEVITY; MAMMAL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0037376173     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(03)00018-8     Document Type: Review

References (52)

1. Martin G.M., Oshima J. Lessons from human progeroid syndromes. Nature. 408:2000;263-266.
2. Bohr V.A. Human premature aging syndromes and genomic instability. Mech. Ageing Dev. 123:2002;987-993.
3. Mohaghegh P., Hickson I.D. Premature aging in RecQ helicase-deficient human syndromes. Int. J. Biochem. Cell Biol. 34:2002;1496-1501.
4. Nakura J., Ye L., Morishima A., Kohara K., Miki T. Helicases and aging. Cell Mol. Life Sci. 57:2000;716-730.
5. Setlow R.B. Human cancer: etiologic agents/dose responses/DNA repair/cellular and animal models. Mutat. Res. 477:2001;1-6.
6. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715.
7. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
8. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis. 21:2000;361-370.
9. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer. 2:2002;594-604.
10. Friedberg EC, Walker GC, Siede W: DNA Repair and Mutagenesis. Washington, DC: ASM Press; 1995.
11. Lehmann A.R. Replication of damaged DNA in mammalian cells: new solutions to an old problem. Mutat. Res. 509:2002;23-34.
12. Dolle M.E., Snyder W.K., Dunson D.B., Vijg J. Mutational fingerprints of aging. Nucleic Acids Res. 30:2002;545-549 Point-mutation spectra from brain, heart, liver, spleen and small intestine of 3.5- and 32-month-old mice were assayed using a lacZ transgenic reporter/plasmid recovery system. Spectra were similar in all tissues of young mice, but differed amongst tissues in old mice, suggesting that organ function, rather than replicative history, is the primary determinant in mutation frequency.
13. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374.
14. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature. 408:2000;433-439.
15. Sugasawa K., Ng J.M., Masutani C., Iwai S., van der Spek P.J., Eker A.P., Hanaoka F., Bootsma D., Hoeijmakers J.H.J. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 2:1998;223-232.
16. Tang J.Y., Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol. Cell. 5:2000;737-744.
17. Le Page F., Kwoh E.E., Avrutskaya A., Gentil A., Leadon S.A., Sarasin A., Cooper P.K. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell. 101:2000;159-171.
18. Woudstra E.C., Gilbert C., Fellows J., Jansen L., Brouwer J., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature. 415:2002;929-933.
19. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ: Nucleotide excision repair syndromes: Xeroderma pigmentosum, Cockayne syndrome and Trichothiodystrophy. In The Metabolic and Molecular Basis of Inherited Disease, vol 1. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, Kinzler KW. McGraw-Hill; 2001:677-703.
20. Friedberg E.C., Cheo D.L., Meira L.B., Reis A.M. Cancer predisposition in mutant mice defective in the XPC DNA repair gene. Prog. Exp. Tumor Res. 35:1999;37-52.
21. Wijnhoven S.W., Kool H.J., Mullenders L.H.M., van Zeeland A.A., Friedberg E.C., van der Horst G.T., van Steeg H., Vrieling H. Age-dependent spontaneous mutagenesis in Xpc mice defective in nucleotide excision repair. Oncogene. 19:2000;5034-5037.
22. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad Sci. USA. 96:1999;424-428.
23. van den Boom V., Jaspers N.G.J., Vermeulen W. When machines get stuck-obstructed RNA polymerase II: displacement. Bioessays. 24:2002;780-784.
24. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42:1992;68-84.
25. van der Horst G.T.J., van Steeg H., Berg R.J., van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., van Kreijl C.F., de Gruijl F.R.et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
26. van der Horst G.T.J., Meira L., Gorgels T.G.M.F., de Wit J., Valesco-Miguel S., Richardson J.A., Kamp Y., Vreeswijk M.P.G., Smit B., Bootsma D.et al. UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA Rep. 1:2002;137-157.
27. Itin P.H., Sarasin A., Pittelkow M.R. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J. Am. Acad. Dermatol. 44:2001;891-921.
28. de Boer J., de Wit J., van Steeg H., Berg R.J., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H.J., Weeda G. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell. 1:1998;981-990.
29. -/- background supports the hypothesis that DNA damage is an underlying cause.
30. Weeda G., Eveno E., Donker I., Vermeulen W., Chevallier-Lagente O., Taieb A., Stary A., Hoeijmakers J.H.J., Mezzina M., Sarasin A. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am. J. Hum. Genet. 60:1997;320-329.
31. Volker M., Mone M.J., Karmakar P., van Hoffen A., Schul W., Vermeulen W., Hoeijmakers J.H., van Driel R., van Zeeland A.A., Mullenders L.H. Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell. 8:2001;213-224 Local UV irradiation combined with immunofluorescence in various nucleotide excision repair (NER)-deficient primary human diploid fibroblasts were used to study the kinetics, order of association and protein requirements of NER. This work establishes NER as a sequential protein assembly process, the XPC-hHR23B dimer as the principal damage recognition complex and that association of XPA occurs after TFIIH recruitment.
32. Citterio E., Vermeulen W., Hoeijmakers J.H.J. Transcriptional healing. Cell. 101:2000;447-450.
33. Harada Y.N., Shiomi N., Koike M., Ikawa M., Okabe M., Hirota S., Kitamura Y., Kitagawa M., Matsunaga T., Nikaido O.et al. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the Xeroderma pigmentosum group G gene. Mol. Cell Biol. 19:1999;2366-2372.
34. Sijbers A.M., van Voorst Vader P.C., Snoek J.W., Raams A., Jaspers N.G., Kleijer W.J. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease. J. Invest. Dermatol. 110:1998;832-836.
35. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat. Genet. 5:1993;217-223.
36. Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers C.J., Nigg A., van Steeg H., Bootsma D., Hoeijmakers J.H.J. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr. Biol. 7:1997;427-439.
37. Osterod M., Hollenbach S., Hengstler J.G., Barnes D.E., Lindahl T., Epe B. Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice. Carcinogenesis. 22:2001;1459-1463.
38. Rouse J., Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science. 297:2002;547-551.
39. INK4a levels in sections of breast tumours, suggesting that DNA-damage-induced senescence is a relevant pathway in vivo.
40. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511:2002;145-178.
41. Wahl G.M., Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol. 3:2001;E277-E286.
42. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348 Using dominant-negative telomere repeat binding factor 2 to trigger telomere dysfunction and cellular senescence, the authors show that p53 and p16/Rb are both required in human diploid fibroblasts for cellular senescence, whereas in low-passage mouse embryonic fibroblasts only p53 is required.
43. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:2002;335-346 Primary mouse lymphomas with defined genetic lesions were generated to unravel the contribution of apoptosis and senescence pathways to response to treatment with the alkylating agent cyclophosphamide. The authors provide the first solid evidence in mice that DNA-damage-induced cellular senescence can occur in vivo.
44. Donehower L.A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7:1996;269-278.
45. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C.et al. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53 The premature ageing symptoms and cancer incidence of two mutant p53 mouse models are described: the p53 'm' allele (Arg245→Trp mutation in exon 7 with an unintended 20 kb deletion including exons 1-6 and potential upstream genes) and a ∼20-copy temperature-sensitive p53 transgene (Ala135→Val).
46. Ferbeyre G., Lowe S.W. The price of tumour suppression? Nature. 415:2002;26-27.
47. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.C., Blasco M.A., Serrano M. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21:2002;6225-6235 Mice carrying one or two copies of a p53-containing bacterial artificial chromosome age normally but have reduced rates of spontaneous and induced tumours. This counters the notion that enhanced DNA-damage signalling is always deleterious.
48. Kirkwood T.B. p53 and ageing: too much of a good thing? Bioessays. 24:2002;577-579.
49. -/- murine embryonic fibroblasts are sensitive to ionising radiation and paraquat, confirming the role of transcription-coupled repair in the resistance to oxidative stress in a species other than humans In addition, the authors show that embryonic stem cells are more sensitive to ionising radiation than fibroblasts, with only minor contributions from CSB or XPA, demonstrating that DNA repair capacity is cell-type- or tissue-specific.
50. Vogel H., Lim D.S., Karsenty G., Finegold M., Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad Sci. USA. 96:1999;10770-10775.
51. Keriel A., Stary A., Sarasin A., Rochette-Egly C., Egly J.M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 109:2002;125-135.
52. Iben S., Tschochner H., Bier M., Hoogstraten D., Hozak P., Egly J.M., Grummt I. TFIIH plays an essential role in RNA polymerase I transcription. Cell. 109:2002;297-306.